ログイン

Patho Cardiovascular 2
56問 • 2年前
  • Two Clean Queens
  • 通報

    問題一覧

  • 1

    Chest pain caused by ischemia

    Angina

  • 2

    Transient pain, caused by accumulation of lactic acid—> ischemic stretching of myocardium—> irritates myocardial nerve fibers

    Stable Angina

  • 3

    Manifestation of pain vary as a result of afferent fibers that transmit pain enter spinal cord from C3-T4

    Stable Angina

  • 4

    Occurs at rest, unpredictable, vasospasm caused by atherosclerosis related to decreased vagal activity, hyperactive SNS, decreased NO activity, altered Ca channel function —> benign or serious dysrththmia

    Unstable (Prinzmetal) Angina

  • 5

    Non-chest pain ischemia. Presents as fatigue, dyspnea or feelings of unease. LV sympathetic innervation, DMII, post-cardiac surgery, mental stress

    Silent Ischemia

  • 6

    Reversible Myocardial Ischemia, Forecasts Impending MI

    Unstable Angina

  • 7

    Prolonged ischemia with irreversible damage to heart muscle, results from rupture of unstable plaque in coronary arteries—> thrombosis of vessel

    MI

  • 8

    Related to superficial plaque erosion—> transient thrombotic vessel occlusion—> vasoconstriction at site. Symptoms: new onset angina, angina at rest> 20 mins, increasing severity or frequency of previous angina. ST depression, T-wave inversion that goes away when pain stops. Normal Trops, CK-MB.

    Unstable Angina

  • 9

    Thrombus breaks up before complete distal necrosis. ST depression and T-wave inversion, elevated cardiac biomarkers. Intervention needed promptly as dislodged is plaque is likely to cause thrombosis elsewhere.

    NSTEMI

  • 10

    Infarction extends through myocardium creating severe cardiac dysfunction. Presents with ST elevation, elevated cardiac biomarkers.

    STEMI

  • 11

    Hypoxia induces

    Cellular injury

  • 12

    Hypoxia induces

    Decreased glycogen stores = anaerobic metabolism

  • 13

    Hypoxia induces

    Increased H+ and lactic acid

  • 14

    Hypoxia induces

    Acidosis

  • 15

    Hypoxia induces

    HF

  • 16

    Hypoxia induces

    Decreased K, Ca, and Mag

  • 17

    Hypoxia induces

    Decreased contractility

  • 18

    Hypoxia induces

    Release of Catecholamines

  • 19

    Hypoxia induces

    Hypoxia induces Norepinephrine—> increase serum glucose

  • 20

    Hypoxia induces

    Angiotensin II—> peripheral vasoconstriction, fluid retention, coronary artery spasm

  • 21

    Hypoxia induces

    Reperfusion injury

  • 22

    Hypoxia induces

    Release of toxic O2 radicals, Ca influx, pH change—> cell death

  • 23

    Hypoxia induces

    Inflammatory cells—> myocardial tissue injury

  • 24

    Temporary loss of comtractile function, last hours-days

    Myocardial stunning

  • 25

    Myocyte hypertrophy, scarring and loss of function distant to area of infarction—> can be limited and reversed with quick restoration of coronary flow

    Myocardial remodeling

  • 26

    Degradation of injured cell—> scar tissue. Decreased contractility, altered LV compliance, decreased stroke volume and EF, increased LV-end diastolic pressure and volume, SA node malfunction.

    Myocardial repair

  • 27

    Dysrhythmia, Cardiogenic Shock, Pericarditis, Ventricular Aneurysm/Rupture, Papillary Muscle Rupture, Thromboembolism

    MI Complications

  • 28

    Elevated Troponin (most specific indicator), CK-MB, LDH, and CRP. leukocytosis and hyperglycemia.

    MI Lab Diagnosis

  • 29

    Inadequate perfusion to tissues and/or increased diastolic filling pressures

    Heart Failure

  • 30

    Inability of heart to generate adequate CO to perfuse tissues, EF <40%, decreaed contractiliy, increaed preload, increased afterload

    Left HFrEF (Systolic HF)

  • 31

    Pulmonary congestion despite normal stroke volume and CO. Decreased compliance in LV, abnormal relaxation of LV (lusittopy), associated with: changes in Ca transport from myocytes, autonomic and endothelial dysfunction

    Left HFpEF (Diastolic HF)

  • 32

    LV doesn’t relax but empties (normal LV end-diastolic volume) but there is increased LV end-diastolic pressure—> increased LV pressure—> pulmonary edema—> pulmonary HTN

    Left HFpEF (Diastolic HF)

  • 33

    Symptoms: dyspnea on exertion, fatigue, crackles, S4 gallop, LV hypertrophy, CXR congestion

    Left HFpEF (Diastolic HF)

  • 34

    Inability to provide adequate blood to lungs at normal CVP. Often caused by LHF and Pulmonary HTN. Initially RV hypertrophy in attempt to compensate for increased pulmonary pressure but ultimately, diastolic and systolic dysfunction—> HF

    Right HF

  • 35

    Symptoms: JVD, peripheral edema, hepatosplenomegaly (systemic symptoms)

    Right HF

  • 36

    B-type natriuretic peptides (BNP)

    Helpful in ruling out HF

  • 37

    Potent vasoconstrictors associated with poor HF prognosis

    Endothelial hormones

  • 38

    Elevated in HF, contribute to myocardial hypertrophy and remodeling, and cardiac cachexia?

    TNF-a and IL-6

  • 39

    Related to activation of SNS and RASS

    Insulin Resistance

  • 40

    Hypertrophy and dilation of ventricle, Large Cells, Impaired Contractility

    Ventricular Remodeling

  • 41

    Valve is narrow and blood flow forward is constricted—> increase workload of chamber

    Stenosis

  • 42

    Valve leaflets don’t close completely, and blood continues to flow when the valve is supposed to be closed—> increases blood flow in chamber affected, increasing workload —> dilation—>hypertrophy

    Regurgitation

  • 43

    Most common valve disease, decreases blood flow from LV—> body, results in LV hypertrophy. Causes: calcification of valve, bicuspid valve, inflammation from rheumatic heart disease.

    Aortic Stenosis

  • 44

    Normal blood flow out of LV in systole but blood flow leaks back into LV during diastole resulting in LA dilation and Hypertrophy. Causes: bicuspid valve, degeneration, HTN, rheumatic heart disease, Marfan’s syndrome.

    Aortic Regurgitation

  • 45

    Mist common rheumatic heart disease, scars leaflets, limits blood flow from LA—> LV. LA hypertrophy—> atrial dysrhythmias and pulmonary edema.

    Mitral Stenosis

  • 46

    Primarily related to mitral valve prolapse. Results in back flow of blood from LV—> LA. LA hypertrophy—> LA dilation—> pulmonary HTN—> RV failure

    Mitral Regurgitation

  • 47

    Most common valve disorder in the US. Associated with inherited tissue disorders and hyperthyroidism. Anterior and posterior cusps of MV billow up. Allow leaking into artium.

    Mitral Valve Prolapse

  • 48

    Infection and inflammation of the endothelium, especially the valves. Staph A most common cause but also associated with other bacteria and viruses. Risks include: prosthetic valves, IV drug use, acquired heart disease, long term IV catheters

    Endocarditis

  • 49

    Symptoms: formations of vegetations, emboli, fever, night sweats, malaise, murmur, regurgitation, HF.

    Endocarditis

  • 50

    Treatment: Antibiotics, Valve repair/replacement, Prophylaxis

    Endocarditis

  • 51

    Amount of blood in Pulmonary Circulation

    9%

  • 52

    Amount of blood in Heart

    7%

  • 53

    Amount of blood in Arteries

    13%

  • 54

    Hypoxia induces Cellular Injury leading to:

    Decreaed glycogen = anaerobic metabolism —> Increaed H+ Lactic Acid —> Acidosis —>HF

  • 55

    Hypoxia Induces Electrolyte Disturbances (Decreased K, Ca, Mg):

    Decreased Contractility—> Release of Catecholamines—> Norepinephrine increases serum glucose—> Angiotensin II causes vasoconstriction, fluid retention, coronary artery spasm

  • 56

    Hypoxia Induces Reperfusion Injury:

    Release of toxic oxygen radicals, calcium influx, pH change —> cell death. Inflammatory cells—> myocardial tissue injury

  • Patho Renal

    Patho Renal

    Two Clean Queens · 100問 · 2年前

    Patho Renal

    Patho Renal

    100問 • 2年前
    Two Clean Queens

    Pathophysiology

    Pathophysiology

    Two Clean Queens · 100問 · 2年前

    Pathophysiology

    Pathophysiology

    100問 • 2年前
    Two Clean Queens

    Patho Immunology

    Patho Immunology

    Two Clean Queens · 34問 · 2年前

    Patho Immunology

    Patho Immunology

    34問 • 2年前
    Two Clean Queens

    Patho Hematology

    Patho Hematology

    Two Clean Queens · 100問 · 2年前

    Patho Hematology

    Patho Hematology

    100問 • 2年前
    Two Clean Queens

    Patho Hematology 2

    Patho Hematology 2

    Two Clean Queens · 76問 · 2年前

    Patho Hematology 2

    Patho Hematology 2

    76問 • 2年前
    Two Clean Queens

    Patho Respiratory

    Patho Respiratory

    Two Clean Queens · 100問 · 2年前

    Patho Respiratory

    Patho Respiratory

    100問 • 2年前
    Two Clean Queens

    Patho Respiratory 2

    Patho Respiratory 2

    Two Clean Queens · 54問 · 2年前

    Patho Respiratory 2

    Patho Respiratory 2

    54問 • 2年前
    Two Clean Queens

    Patho Cardiovascular

    Patho Cardiovascular

    Two Clean Queens · 100問 · 2年前

    Patho Cardiovascular

    Patho Cardiovascular

    100問 • 2年前
    Two Clean Queens

    Patho MSK

    Patho MSK

    Two Clean Queens · 52問 · 2年前

    Patho MSK

    Patho MSK

    52問 • 2年前
    Two Clean Queens

    Patho Acid Base

    Patho Acid Base

    Two Clean Queens · 35問 · 2年前

    Patho Acid Base

    Patho Acid Base

    35問 • 2年前
    Two Clean Queens

    Renal 2

    Renal 2

    Two Clean Queens · 10問 · 2年前

    Renal 2

    Renal 2

    10問 • 2年前
    Two Clean Queens

    Fluid Balance

    Fluid Balance

    Two Clean Queens · 43問 · 2年前

    Fluid Balance

    Fluid Balance

    43問 • 2年前
    Two Clean Queens

    Patho Endocrine

    Patho Endocrine

    Two Clean Queens · 100問 · 2年前

    Patho Endocrine

    Patho Endocrine

    100問 • 2年前
    Two Clean Queens

    Patho Endocrine 2

    Patho Endocrine 2

    Two Clean Queens · 42問 · 2年前

    Patho Endocrine 2

    Patho Endocrine 2

    42問 • 2年前
    Two Clean Queens

    Infections

    Infections

    Two Clean Queens · 58問 · 2年前

    Infections

    Infections

    58問 • 2年前
    Two Clean Queens

    Patho Shock

    Patho Shock

    Two Clean Queens · 31問 · 2年前

    Patho Shock

    Patho Shock

    31問 • 2年前
    Two Clean Queens

    GI

    GI

    Two Clean Queens · 100問 · 2年前

    GI

    GI

    100問 • 2年前
    Two Clean Queens

    GI 2

    GI 2

    Two Clean Queens · 18問 · 2年前

    GI 2

    GI 2

    18問 • 2年前
    Two Clean Queens

    Cancer

    Cancer

    Two Clean Queens · 54問 · 2年前

    Cancer

    Cancer

    54問 • 2年前
    Two Clean Queens

    問題一覧

  • 1

    Chest pain caused by ischemia

    Angina

  • 2

    Transient pain, caused by accumulation of lactic acid—> ischemic stretching of myocardium—> irritates myocardial nerve fibers

    Stable Angina

  • 3

    Manifestation of pain vary as a result of afferent fibers that transmit pain enter spinal cord from C3-T4

    Stable Angina

  • 4

    Occurs at rest, unpredictable, vasospasm caused by atherosclerosis related to decreased vagal activity, hyperactive SNS, decreased NO activity, altered Ca channel function —> benign or serious dysrththmia

    Unstable (Prinzmetal) Angina

  • 5

    Non-chest pain ischemia. Presents as fatigue, dyspnea or feelings of unease. LV sympathetic innervation, DMII, post-cardiac surgery, mental stress

    Silent Ischemia

  • 6

    Reversible Myocardial Ischemia, Forecasts Impending MI

    Unstable Angina

  • 7

    Prolonged ischemia with irreversible damage to heart muscle, results from rupture of unstable plaque in coronary arteries—> thrombosis of vessel

    MI

  • 8

    Related to superficial plaque erosion—> transient thrombotic vessel occlusion—> vasoconstriction at site. Symptoms: new onset angina, angina at rest> 20 mins, increasing severity or frequency of previous angina. ST depression, T-wave inversion that goes away when pain stops. Normal Trops, CK-MB.

    Unstable Angina

  • 9

    Thrombus breaks up before complete distal necrosis. ST depression and T-wave inversion, elevated cardiac biomarkers. Intervention needed promptly as dislodged is plaque is likely to cause thrombosis elsewhere.

    NSTEMI

  • 10

    Infarction extends through myocardium creating severe cardiac dysfunction. Presents with ST elevation, elevated cardiac biomarkers.

    STEMI

  • 11

    Hypoxia induces

    Cellular injury

  • 12

    Hypoxia induces

    Decreased glycogen stores = anaerobic metabolism

  • 13

    Hypoxia induces

    Increased H+ and lactic acid

  • 14

    Hypoxia induces

    Acidosis

  • 15

    Hypoxia induces

    HF

  • 16

    Hypoxia induces

    Decreased K, Ca, and Mag

  • 17

    Hypoxia induces

    Decreased contractility

  • 18

    Hypoxia induces

    Release of Catecholamines

  • 19

    Hypoxia induces

    Hypoxia induces Norepinephrine—> increase serum glucose

  • 20

    Hypoxia induces

    Angiotensin II—> peripheral vasoconstriction, fluid retention, coronary artery spasm

  • 21

    Hypoxia induces

    Reperfusion injury

  • 22

    Hypoxia induces

    Release of toxic O2 radicals, Ca influx, pH change—> cell death

  • 23

    Hypoxia induces

    Inflammatory cells—> myocardial tissue injury

  • 24

    Temporary loss of comtractile function, last hours-days

    Myocardial stunning

  • 25

    Myocyte hypertrophy, scarring and loss of function distant to area of infarction—> can be limited and reversed with quick restoration of coronary flow

    Myocardial remodeling

  • 26

    Degradation of injured cell—> scar tissue. Decreased contractility, altered LV compliance, decreased stroke volume and EF, increased LV-end diastolic pressure and volume, SA node malfunction.

    Myocardial repair

  • 27

    Dysrhythmia, Cardiogenic Shock, Pericarditis, Ventricular Aneurysm/Rupture, Papillary Muscle Rupture, Thromboembolism

    MI Complications

  • 28

    Elevated Troponin (most specific indicator), CK-MB, LDH, and CRP. leukocytosis and hyperglycemia.

    MI Lab Diagnosis

  • 29

    Inadequate perfusion to tissues and/or increased diastolic filling pressures

    Heart Failure

  • 30

    Inability of heart to generate adequate CO to perfuse tissues, EF <40%, decreaed contractiliy, increaed preload, increased afterload

    Left HFrEF (Systolic HF)

  • 31

    Pulmonary congestion despite normal stroke volume and CO. Decreased compliance in LV, abnormal relaxation of LV (lusittopy), associated with: changes in Ca transport from myocytes, autonomic and endothelial dysfunction

    Left HFpEF (Diastolic HF)

  • 32

    LV doesn’t relax but empties (normal LV end-diastolic volume) but there is increased LV end-diastolic pressure—> increased LV pressure—> pulmonary edema—> pulmonary HTN

    Left HFpEF (Diastolic HF)

  • 33

    Symptoms: dyspnea on exertion, fatigue, crackles, S4 gallop, LV hypertrophy, CXR congestion

    Left HFpEF (Diastolic HF)

  • 34

    Inability to provide adequate blood to lungs at normal CVP. Often caused by LHF and Pulmonary HTN. Initially RV hypertrophy in attempt to compensate for increased pulmonary pressure but ultimately, diastolic and systolic dysfunction—> HF

    Right HF

  • 35

    Symptoms: JVD, peripheral edema, hepatosplenomegaly (systemic symptoms)

    Right HF

  • 36

    B-type natriuretic peptides (BNP)

    Helpful in ruling out HF

  • 37

    Potent vasoconstrictors associated with poor HF prognosis

    Endothelial hormones

  • 38

    Elevated in HF, contribute to myocardial hypertrophy and remodeling, and cardiac cachexia?

    TNF-a and IL-6

  • 39

    Related to activation of SNS and RASS

    Insulin Resistance

  • 40

    Hypertrophy and dilation of ventricle, Large Cells, Impaired Contractility

    Ventricular Remodeling

  • 41

    Valve is narrow and blood flow forward is constricted—> increase workload of chamber

    Stenosis

  • 42

    Valve leaflets don’t close completely, and blood continues to flow when the valve is supposed to be closed—> increases blood flow in chamber affected, increasing workload —> dilation—>hypertrophy

    Regurgitation

  • 43

    Most common valve disease, decreases blood flow from LV—> body, results in LV hypertrophy. Causes: calcification of valve, bicuspid valve, inflammation from rheumatic heart disease.

    Aortic Stenosis

  • 44

    Normal blood flow out of LV in systole but blood flow leaks back into LV during diastole resulting in LA dilation and Hypertrophy. Causes: bicuspid valve, degeneration, HTN, rheumatic heart disease, Marfan’s syndrome.

    Aortic Regurgitation

  • 45

    Mist common rheumatic heart disease, scars leaflets, limits blood flow from LA—> LV. LA hypertrophy—> atrial dysrhythmias and pulmonary edema.

    Mitral Stenosis

  • 46

    Primarily related to mitral valve prolapse. Results in back flow of blood from LV—> LA. LA hypertrophy—> LA dilation—> pulmonary HTN—> RV failure

    Mitral Regurgitation

  • 47

    Most common valve disorder in the US. Associated with inherited tissue disorders and hyperthyroidism. Anterior and posterior cusps of MV billow up. Allow leaking into artium.

    Mitral Valve Prolapse

  • 48

    Infection and inflammation of the endothelium, especially the valves. Staph A most common cause but also associated with other bacteria and viruses. Risks include: prosthetic valves, IV drug use, acquired heart disease, long term IV catheters

    Endocarditis

  • 49

    Symptoms: formations of vegetations, emboli, fever, night sweats, malaise, murmur, regurgitation, HF.

    Endocarditis

  • 50

    Treatment: Antibiotics, Valve repair/replacement, Prophylaxis

    Endocarditis

  • 51

    Amount of blood in Pulmonary Circulation

    9%

  • 52

    Amount of blood in Heart

    7%

  • 53

    Amount of blood in Arteries

    13%

  • 54

    Hypoxia induces Cellular Injury leading to:

    Decreaed glycogen = anaerobic metabolism —> Increaed H+ Lactic Acid —> Acidosis —>HF

  • 55

    Hypoxia Induces Electrolyte Disturbances (Decreased K, Ca, Mg):

    Decreased Contractility—> Release of Catecholamines—> Norepinephrine increases serum glucose—> Angiotensin II causes vasoconstriction, fluid retention, coronary artery spasm

  • 56

    Hypoxia Induces Reperfusion Injury:

    Release of toxic oxygen radicals, calcium influx, pH change —> cell death. Inflammatory cells—> myocardial tissue injury